CAR T CELL THERAPY
Clinical trials for CAR T CELL THERAPY explained in plain language.
Never miss a new study
Get alerted when new CAR T CELL THERAPY trials appear
Sign up with your email to follow new studies for CAR T CELL THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on tough lymphoma
Disease control Recruiting nowThis study tests a new treatment for people with diffuse large B-cell lymphoma (DLBCL) that has come back or not responded to at least two prior therapies. The treatment uses a patient's own immune cells, which are genetically modified to recognize and attack cancer cells. The go…
Matched conditions: CAR T CELL THERAPY
Phase: PHASE2 • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated May 17, 2026 04:36 UTC
-
New CAR-T therapy targets tough leukemia in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment called A-CAR028 for people with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The treatment uses specially engineered immune cells (CAR-T cells) to attack the cancer. The main goals are to check …
Matched conditions: CAR T CELL THERAPY
Phase: PHASE1 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New CAR-T therapy takes on hard-to-treat lung cancer
Disease control Recruiting nowThis early study tests a new treatment called TC-D101 for people with a specific type of advanced small cell lung cancer that has come back or not responded to standard treatments. The therapy uses specially engineered immune cells (CAR-T cells) to target a protein called DLL3 on…
Matched conditions: CAR T CELL THERAPY
Phase: EARLY_PHASE1 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Engineered immune cells take on aggressive MS in first human trial
Disease control Recruiting nowThis study tests a new treatment called MB-CART 2019.1 for people with active multiple sclerosis (MS) that hasn't responded to other therapies. The treatment uses a patient's own immune cells, modified in a lab to target and attack harmful immune cells driving MS. The goal is to …
Matched conditions: CAR T CELL THERAPY
Phase: PHASE1, PHASE2 • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New program helps cancer therapy survivors step up their recovery
Symptom relief Recruiting nowThis study tests a program that combines in-person and app-based coping skills training with activity coaching for people who have had a stem cell transplant or CAR-T therapy. The goal is to help them manage symptoms like pain, fatigue, and stress so they can be more active and r…
Matched conditions: CAR T CELL THERAPY
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated May 17, 2026 04:34 UTC
-
Can a smartphone app help CAR-T patients? new trial seeks answers
Symptom relief Recruiting nowThis study tests a mobile app called THRIVE-CAR-T designed to support patients undergoing CAR-T cell therapy for blood cancers. The goal is to see if the app is practical and acceptable to patients. About 100 adults will participate, and the study focuses on how many people use t…
Matched conditions: CAR T CELL THERAPY
Phase: NA • Sponsor: Patrick C. Johnson, MD • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
New study aims to predict brain complications from CAR T-Cell therapy
Knowledge-focused Recruiting nowThis study looks at why some people getting CAR T-cell therapy for cancer develop brain-related side effects called neurotoxicity. Researchers will use brain scans, thinking tests, and blood tests to find early warning signs. The goal is to create a tool that can predict which pa…
Matched conditions: CAR T CELL THERAPY
Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated May 17, 2026 04:15 UTC